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Abstract: Feline immunodeficiency virus (FIV) infection results in viral persistence, a prolonged
asymptomatic phase, and progressive immunopathology. During the asymptomatic phase, a cohort
of experimentally FIV-infected cats exhibits features of viral latency in blood suggestive of inactive
viral replication. We sought to investigate viral replication activity and genomic stability of the FIV
proviral long terminal repeat (LTR) and the 5’ aspect of gag over time. FIV-infected cats during the
asymptomatic phase demonstrated undetectable plasma FIV gag RNA transcripts and intermittent to
undetectable blood-derived cell-associated FIV gag RNA. The LTR sequence demonstrated instability
in blood-derived cells over time, in spite of low to undetectable viral replication. Sequence variation
in the LTR was identified in CD4+ and CD21+ leukocytes from blood and surgically removed
lymph nodes. Three single nucleotide polymorphisms (SNPs) in the LTR were commonly identified.
Promoter functionality of a common LTR SNP and rare U3 mutation were examined by reporter gene
assays and demonstrated either no change or increased basal FIV promoter function, respectively.
In conclusion, this cohort of asymptomatic FIV-infected cats demonstrated instability of the LTR and
5’ gag sequences during the study period, in spite of undetectable plasma and rare to undetectable
viral gag RNA, which suggests that blood may not accurately represent viral activity in asymptomatic
FIV-infected cats.
Keywords: FIV; latency; promoter; LTR; gag; lymph node; asymptomatic; lentivirus
1. Introduction
Feline immunodeficiency virus (FIV) of the family Retroviridae, subfamily Orthoretrovirinae, and
genus Lentivirus, is the cause of a life-long, progressive immunocompromising disease affecting
domestic cats worldwide [1,2]. FIV-infection typically progresses through three clinical phases in
the cat; the acute, asymptomatic and terminal immunodeficiency phase [3]. In the acute phase of
infection, there is prolific viral replication with broad viral distribution to lymphoid organs and many
immune cell subsets including CD4+ T cells, CD8+ T cells, B-cells and monocytes/macrophages [3].
Clinically, the acute phase is characterized by high plasma viremia, a transient drop in peripheral
blood CD4+ T cell numbers, fever and lymphadenopathy [3]. This is followed by the asymptomatic
phase, which may last months to years, where the infected cat generally has no outward sign of clinical
disease (clinical latency). However, on closer examination FIV-infected cats in the asymptomatic phase
demonstrate multiple immunopathologies such as progressively declining numbers of peripheral
blood CD4+ T cells, a persistently inverted CD4/CD8 ratio, cytokine aberrations and immune cell
function abnormalities [3]. In the terminal immunodeficiency phase, viral replication rebounds in the
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face of immunopathology resulting in high plasma viremia, immune system failure, opportunistic
infections or neoplasia [3]. The late asymptomatic phase of infection and associated viral activity
remain under-investigated, possibly due to the cost of maintaining experimentally infected cats for
prolonged periods of time. We sought to understand viral replication activity and the evolution of the
proviral genome within infected cats during the asymptomatic phase. A more detailed understanding
of this phase, along with that of the terminal immunodeficiency phase of disease, may facilitate the
development of medical intervention strategies to prolong the asymptomatic phase or potentially
eradicate the virus.
Our laboratory has established a cohort of experimentally FIV-infected cats where viral activity
and immunopathology in the peripheral blood have been closely monitored over time. A detailed
description of the acute phase and progression into the early asymptomatic phase for these cats
has previously been reported on by our group [4]. In short, these cats reached a peak viremia
approximately two weeks post inoculation that ranged from 4.9 ˆ 104 to 5.8 ˆ 106 copies vRNA/mL of
plasma, followed by variable detection thereafter. Both proviral DNA and viral gag RNA were readily
detectable in PBMCs. Approximately ten months post-inoculation, the cats entered the asymptomatic
phase characterized by the absence of outward clinical disease and undetectable plasma viremia
(clinical latency). We have identified several features of these infected cats that are consistent with
the concept of viral latency including persistently undetectable plasma viral RNA, evidence that the
FIV viral promoter is associated with a condensed chromatin pattern in peripheral blood CD4+ cells,
and the presence of abundant short R-transcripts in CD4+ cells [3–6]. These features suggest that
viral replication in the peripheral blood during the asymptomatic phase is either absent or present
at a level below the limits of detection. It is a well-recognized and inherent feature of retroviral
pathogenesis that proviral mutations accumulate as replication and cellular infection occur due to the
lack of proofreading mechanisms in the viral polymerase, a relative infidelity of reverse transcription,
and viral recombination in vivo [7–9]. As a result, it seems plausible that asymptomatic FIV-infected
cats demonstrating persistently undetectable plasma viremia and viral latency in peripheral CD4+
cells would exhibit proviral sequence stability over time. We sought to further characterize viral
activity in the peripheral blood during the asymptomatic phase by serially monitoring plasma and
PBMC-associated viral gag RNA, and hypothesized that asymptomatic FIV-infected cats would
demonstrate persistent inactive viral transcription in the peripheral blood, and genomic stability
of the integrated provirus.
2. Materials and Methods
2.1. Animals and Sample Procurement
Six specific pathogen free cats were procured at approximately six months of age and housed
at the University of California Davis Feline Research Colony facility. Four of the cats received
an intramuscular injection containing 106 TCID50 of FIV-C (Clade C Paddy-gammer strain) [4].
Two cats served as negative control animals and received an injection of virus-free sterile media.
A previous report of cats experimentally infected with the FIV-C Paddy-gammer strain of virus
indicated rapid disease progression, which did not occur in the cohort of cats reported here [10].
In fact, experimental infection with this strain resulted in quite the opposite. Our cats have
experienced a very prolonged disease course with an extensive asymptomatic phase, which has
given us the opportunity to investigate mechanisms of viral latency, tissue reservoirs, and viral
evolution in vivo. Animals were monitored by physical examination for signs of illness, and peripheral
blood collected biweekly to monthly. Approximately 10 months post-inoculation all of the cats entered
the asymptomatic phase of infection where clinical signs of disease were absent (fever, cutaneous or
gingival inflammation, lymphadenopathy, inappetence and/or lethargy) and plasma viral gag RNA
was persistently undetectable by real-time PCR methods [4]. For this study, viral gag RNA transcription
and proviral LTR sequence analysis were examined from PBMCs collected intermittently between the
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150–300 weeks post-inoculation (wpi) study period. Between weeks 274–290 wpi, bilateral popliteal
lymph nodes (PLNs) were surgically removed in order to compare lymphoid tissue-derived proviral
LTR sequences to peripheral blood derived cells [11]. Proviral sequence analysis was extended to
the 51 aspect of the FIV gag segment (~1000 nucleotides) in lymph node-derived leukocytes, which
was compared to the sequence of the inoculating virus. Based on our hypothesis, the expectation
was that lymphoid tissue FIV proviral sequences (LTR and gag) would exhibit stability relative
to the inoculating virus. All experimental study protocols were approved by the University of
California Davis Institutional Animal Care and Use Committee (IACUC, permit #18155). The surgical
pharmaceutical protocol included a subcutaneous premedication injection of atropine (0.02 mg/kg)
and butorphanol (0.3 mg/kg), intravenous induction with ketamine (5 mg/kg) and midazolam
0.5 mg/kg, inhalational anesthesia maintenance with oxygen and 2% isoflurane via an endotracheal
tube, and intraoperative intravenous ampicillin (20 mg/kg). Post-operative medications consisted of
buprenorphine (0.02 mg/kg) administered transmucosally twice daily for 3–7 days as needed, and
amoxicillin trihydrate/clavulanate potassium given orally twice daily (6.25 mg/lb) for 10 days.
2.2. Viral Transcription Status in Peripheral Blood over Time
At multiple time points between 150 and 300 wpi, 10 mL of blood were collected by jugular
venipuncture and separated into plasma and PBMC fractions as previously described [4]. Viral RNA
was extracted from 140 µL of plasma using a commercial kit (QIAamp Viral RNA Mini Kit, Qiagen,
Valencia, CA, USA) and cell-associated RNA and DNA were co-extracted from 5 ˆ 106 PBMCs using
the Allprep DNA/RNA Mini Kit (Qiagen). Plasma and PBMC fractions were examined for the
presence of viral gag RNA by real-time polymerase chain reaction (PCR) methods [4], as the presence
of detectable viral RNA in either fraction serves as evidence of active viral transcription. Between ten
to fifteen plasma and eight to ten PBMC samples were collected from each FIV-infected and negative
control cat during the study period with at least one month between collections for a particular
cat. PBMCs from the FIV-infected cats were additionally interrogated between 258 and 262 wpi for
the presence of short viral promoter proximal R-transcript RNA, a 66 nucleotide region of the LTR.
Detectable short promoter proximal RNA transcripts, in the absence of detectable viral gag RNA,
have been identified as a signature of viral latency as they indicate that RNA polymerase complex is
paused on the promoter [5,12]. For this procedure, cell-associated RNA was extracted from 5 ˆ 106
PBMCs by the TRIzol method (Invitrogen, Carlsbad, CA, USA). All kit and TRIzol RNA extracts were
DNAse treated (Turbo DNAse, Ambion, Carlsbad, CA, USA), reverse transcribed (Origene First Strand
cDNA Synthesis Kit, Rockville, MD, USA) and interrogated by quantitative polymerase chain reaction
(q-PCR) using FIV gag, feline GAPDH, and short R-transcript primers as previously described [4,5].
This real-time PCR assay has a detection limit of approximately 10 copies of FIV gag complimentary
DNA (cDNA)/sample (data not shown) or 103 copies of FIV gag cDNA per mL of feline plasma.
2.3. Sequence Instability of the Proviral LTR and gag Isolated from PBMC and PLN-Derived Leukocytes
The FIV LTR was PCR amplified from DNA extracted from PBMCs (as described above) and
cloned using pCR2.1 TA cloning kit (Invitrogen) as previously described [6]. For each isolate, 5 clones
were selected for sequencing. Amplified plasmid DNA was purified using a commercial kit (Wizard
Plus SV Minipreps DNA Purification System, Promega, Madison, WI) and sequenced by a local vendor
(Davis Sequencing, Davis, CA, USA). Sequences were analyzed for single nucleotide polymorphisms
(SNPs), insertions, and deletions relative to the inoculating viral sequence.
In an attempt to further characterize the integrated provirus in the FIV-infected cats we examined
the proviral LTR sequence of two known FIV cellular reservoirs, CD4+ and CD21+ leukocytes derived
from both blood and popliteal lymph nodes at a single time point (between 274 and 290 wpi, depending
on the cat). Surgical removal of the popliteal lymph node, leukocyte preparation and CD4+ and CD21+
leukocyte enrichment have been described previously [11]. DNA extraction, PCR amplification, cloning
and sequencing procedures were as described above. Additionally, from unfractionated PLN-derived
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leukocytes, the first ~1000 nucleotides of the gag leader, gag capsid (CA) and 5’ terminus of gag matrix
(MA) were PCR amplified, cloned and compared to the inoculating viral sequence using primers
FIV gag leader for (GTTGGCGCCCGAACAGGGA) and FIV c rev (TAATGGGGATAGGGCTGACTCA).
2.4. Promoter Functionality Assays
We investigated the promoter functionality of the common T329G SNP, and another unusual
mutation detected from enriched blood-derived CD21+ leukocytes of cat 186 with a 52 base pair direct
repeat insertion in U3 of the LTR. A beta-galactosidase reporter assay was performed to assess the
functionality of the FIV promoter with these two individual mutations. From the plasmid shuttle vector
described above (pCR 2.1, Life Technologies, Carlsbad, CA, USA) the FIV LTR clones were moved
into a reporter plasmid (pBlue TOPO TA Expression Kit, Life Technologies). The reporter plasmid
was used to assess the basal transcriptional activity of the inserted FIV promoters in transfected 293T
cells (Lipofectamine 2000 Transfection Reagent, Life Technologies, Carlsbad, CA, USA). This was
achieved by inserting the FIV promoter 5’ to the pBlue TOPO lacZ gene, which encodes a portion of
the enzyme β-galactosidase. Expression experiments were performed in triplicate in 6-well tissue
culture plates as described previously [13]. For each experiment, positive and negative control
plasmids were transfected in parallel. The positive control used was referred to as CMV (pcDNA
3.1D/V5-His/lacZ, Life Technologies) containing a constitutively active cytomegalovirus promoter
5’ to the β-galactosidase reporter gene. The negative controls were either no plasmid (abbreviated
“no tx”) or the β-galactosidase reporter plasmid lacking an upstream promoter (empty). Results for
transfected wells were statistically evaluated by ANOVAs followed by Tukey multiple comparison
tests to determine significant differences; a value of p < 0.05 was considered significant.
3. Results
3.1. Viral Transcription Status in Peripheral Blood over Time
In order to examine the viral replication status in peripheral blood over time, approximately 10 mL
of blood were collected by jugular venipuncture from four asymptomatic experimentally FIV-infected
and two mock-infected negative control cats at multiple time points between 150 and 300 wpi and
separated into plasma and PBMC fractions as described in the Materials and Methods. Plasma viral gag
RNA was undetectable in all cats for the entire study period (150–300 wpi, Figure 1a). PBMC-associated
viral gag RNA was detected in 9 out of 36 samples tested, and only within the first 70 weeks of the study
period (between 150 and 220 wpi, Figure 1b). Each of the FIV-infected cats had at least one positive
result, and at greatest three. PBMC-associated viral gag RNA was not detected in any sample between
220 and 300 wpi. Proviral gag DNA was detectable from PBMCs at all time points in FIV-infected
cats. Neither viral gag DNA or RNA were detected at any time point in the plasma or PBMC samples
from the uninfected negative control cats. Consistent with the concept of cellular latency, abundant
short promoter-proximal R-transcripts were detected from unfractionated PBMCs of all four cats
between 258 and 262 wpi, while FIV gag RNA remained undetectable (Table 1). Collectively these
results indicate that there was a period between 150 and 220 wpi where viral transcription occurred
intermittently but rarely within PBMCs, while viral RNA was undetectable in concurrently collected
plasma samples. Collectively, these data are consistent with peripheral blood viral latency in the
second half of the study period.
Abundant short promoter R-segment transcripts were amplified from all four FIV-infected cats,
while viral gag transcripts were undetectable from peripheral blood PBMCs, consistent with viral
latency and pausing of the RNA polymerase on the FIV promoter. Data are presented as the mean
(˘standard deviation) of triplicate PCR measurements per 106 copies feline GAPDH cDNA, and are
representative of PBMCs at 258–262 weeks post-infection for each cat. BLD indicates values below the
limit of detection.
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in both plasma and PBMCs during the periods that abundant short proximal promoter R-transcripts 
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Figure 1. Plasma and PBMC-associated viral gag R A in asymptomatic FIV-infected cats over time.
(a) Viral gag RNA was undetectable by real-ti e assays in the plasma of all four FIV-infected
cats for the entire study period (150–30 weeks culation, each diamond represent a single
plasm sample from an i div dual FIV-infecte rarely, but intermittently de cted in PBMCs
betw en 150 and 220 wpi; (b) Viral g g RNA was intermittently detectable in the first half of the study
period and undetectable in PBMCs between 220 and 300 wpi. Viral gag RNA was undetectable in both
plasma and PBMCs during the periods that abundant short proximal promoter R-transcripts were
amplified (blue bracket, 258–262 wpi) and the popliteal lymph nodes were surgically removed (red
bracket; 274–290 wpi). Black = cat 187, blue = 184, red = 165, green = 186.
Table 1. Real-time PCR amplifications of viral gag and short promoter R-segment cDNA isolated
from PBMCs.
Cat # PBMC gag cDNA Short R Copies
165 BLD 8.4 ˆ 105 ˘ 3.6 ˆ 105
184 BLD 1.31 ˆ 106 ˘ 3.9 ˆ 105
186 BLD 1.69 ˆ 107 ˘ 4.8 ˆ 106
187 BLD 2.44 ˆ 107 ˘ 4.3 ˆ 106
3.2. Sequence Stability of the Proviral LTR and gag Isolated from PBMC and PLN-Derived Leukocytes
To address the hypothesis that proviral genome stability would be maintained in asymptomatic
FIV-infected cats over time, we PCR amplified, cloned and sequenced the entire FIV LTR from
PBMC-derived DNA at multiple time points between 150 and 300 wpi. The proviral LTR sequence
corresponding to the inoculating virus was rarely amplified from any of the infected cats throughout
the study period (Figure 2). Proviral LTR sequences were examined for the presence of single/multiple
nucleotide polymorphisms (SNPs), insertions and deletions. Single or multiple mutations were
detected most frequently in the U3 region of the LTR, followed by the U5 and then the R segment.
SNPs in the U3 region of the LTR occurred both within and outside of transcription factor binding sites
(TFBS) and the TATA box. A summary of all SNPs detected in the FIV LTR from PBMCs is presented
in Figure 3. Three SNPs were amplified (GenBank submission 1890989) most commonly including
an adenine substitution for guanine at nucleotide 93 in U3 (G93A), occurring at an AP1 transcription
factor-binding site; an adenine substitution for cytosine at nucleotide 102 (C102A); and a guanine
substitution for thymine at nucleotide 329 of U5 (T329G). We have previously reported that the U5
SNP (T329G) was present as a rare variant in the inoculating virus stock of the cats [6], however it was
not detected in vivo in any of the cats until after 150 wpi. Interestingly, the three most common SNPs
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were amplified from all four infected cats with the exception of the G93A mutation, which was not
amplified from cat 186.
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Vet. Sci. 2016, 3, 10 7 of 13 
 
 
Figure 3. Summary of the FIV proviral LTR point mutations detected during the asymptomatic phase 
from all FIV-infected cats over time. Three SNPs were commonly detected (denoted by blue arrows). 
Nucleotide positions where mutations were detected are red and the number above the sequence 
indicates of number of times a particular mutation was detected. Known transcription factor binding 
sites are in green and the TATA box is underlined by black triangles.  
When the proviral LTR sequences from enriched CD4+ and CD21+ leukocyte populations 
derived from blood or PLN were examined, we observed that mutated virus was more commonly 
amplified than wild-type virus from the infected cats’ leukocyte subsets with the exception of cat 184 
CD21+ leukocytes. Again, the most frequently mutated region of the LTR was determined to be the 
U3 region in both cell types of both compartments (Figure 4). The three most commonly amplified 
LTR mutations (G93A, C102A, T329G) were amplified from both blood-derived and PLN leukocytes. 
The proviral LTR was difficult to amplify from peripheral blood CD4+ cells at the late 274–290 wpi 
time point; this was not the case for lymph node-derived CD4+ cells collected in parallel. This is 
likely due to the marked depletion of CD4+ cells in the peripheral blood over the course of infection 
(cat 165 had 98 CD4 cells/μL) and the rarity of FIV-infected peripheral CD4+ cells (estimated to be 1 
infected cell in 1000 CD4+ cells) [5,6]. There were multiple SNPs unique to PLN-derived leukocytes, 
though mutations shared between blood and PLN leukocytes were just as commonly amplified. A 
unique and interesting 52 base pair direct repeat insertion in the U3 region resulting in a duplication 
of the NF-1 and ATF TFBS and the TATA box was amplified from PLN-derived CD21+ leukocytes 
from cat 186 (Figure 5). 
Figure 3. Summary of the FIV proviral LTR point mutations detected during the asymptomatic phase
from all FIV-infected cats over time. Three SNPs were commonly detected (denoted by blue arrows).
Nucleotide positions where mutations were detected are red and the number above the sequence
indicates of number of times a particular mutation was detected. Known transcription factor binding
sites are in green and the TATA box is underlined by black triangles.
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When the proviral LTR sequences from enriched CD4+ and CD21+ leukocyte populations derived
from blood or PLN were examined, we observed that mutated virus was more commonly amplified
than wild-type virus from the infected cats’ leukocyte subsets with the exception of cat 184 CD21+
leukocytes. Again, the most frequently mutated region of the LTR was determined to be the U3 region
in both cell types of both compartments (Figure 4). The three most commonly amplified LTR mutations
(G93A, C102A, T329G) were amplified from both blood-derived and PLN leukocytes. The proviral
LTR was difficult to amplify from peripheral blood CD4+ cells at the late 274–290 wpi time point;
this was not the case for lymph node-derived CD4+ cells collected in parallel. This is likely due to
the marked depletion of CD4+ cells in the peripheral blood over the course of infection (cat 165 had
98 CD4 cells/µL) and the rarity of FIV-infected peripheral CD4+ cells (estimated to be 1 infected cell in
1000 CD4+ cells) [5,6]. There were multiple SNPs unique to PLN-derived leukocytes, though mutations
shared between blood and PLN leukocytes were just as commonly amplified. A unique and interesting
52 base pair direct repeat insertion in the U3 region resulting in a duplication of the NF-1 and ATF
TFBS and the TATA box was amplified from PLN-derived CD21+ leukocytes from cat 186 (Figure 5).Vet. Sci. 2016, 3, 10 8 of 13 
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The 5’ aspect of the FIV gag segment was PCR amplified (~1000 bp), cloned and sequenced from
unfractionated PLN-derived leukocytes of all four cats. Multiple SNPs and deletions were identified
relative to the inoculating virus (Figure 6, GenBank submission 1890989). Mutations were identified
in regions known to be important for efficient encapsidation, and within the matrix and capsid open
reading frames. Mutations did not appear to occur more commonly in any particular region.
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3.3. Promoter Functionality Assays
Our group previously demonstrated that the G93A LTR mutation within an AP-1 TFBS abolishes
the basal promoter transcriptional activity, while the C102A mutation has no apparent effect on the
promoter relative to the wild type sequence [4]. We sought to similarly characterize the effect of the
T329G SNP and another unusual mutation detected from enriched blood-derived CD21+ leukocytes of
cat 186 at 278 wpi, in which there was a 52 base pair direct repeat insertion in U3 of the LTR (Figure 5,
GenBank submission 1890989). In transfected human fetal kidney cells (293T), the T329G mutation
had no effect on basal promoter expression levels relative to the wild-type FIV LTR, while the 52 base
pair inserted repeat significantly amplified FIV promoter expression above basal promoter expression
(Figure 7).
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promoter results in augmentation of promoter function in an in vitro reporter assay. The promoter of the
inoculating virus and the promoter with the T329G SNP demonstrate strong basal promoter function
in human 293T cells relative to negative controls (no transfection and a promoterless β-galactosidase
plasmid-“no tx” and “empty”, respectively). The promoter function with the common T329G SNP was
not significantly (N.S.) different from the wild type inoculating FIV promoter (a); Cells transfected
with the proviral U3 direct repeat mutant demonstrated a basal promoter function significantly above
the wild type inoculating FIV promoter (b). Cells transfected with a CMV-β galactosidase plasmid
(CMV) served as a positive control. An asterisk denotes statistical significance for selected pairwise
comparisons (* p < 0.05) and error bars denote standard deviation.
4. Discussion
In this study we demonstrated instability in the FIV proviral LTR and 5’ aspect of the gag region
over time in the late asymptomatic phase, in spite of low cell-associated viral transcription in the
peripheral blood in the first half of the study period and undetectable viral transcription in the second
half. These findings are inconsistent with our hypothesis that asymptomatic FIV-infected cats would
demonstrate persistent inactive viral transcription in the peripheral blood, and genomic stability of
the integrated provirus. In fact, we demonstrated that these asymptomatic cats transitioned from a
relatively quiescent but intermittently active viral replication status in the peripheral blood, to an
inactive transcription status at around 220 wpi, and new mutations continued to arise in the proviral
LTR sequence regardless of the viral activity status of the peripheral blood. This suggests either a
level of ongoing viral replication below the level of detection in the peripheral blood, or alternatively,
that ongoing viral replication occurs during the asymptomatic phase in solid tissue reservoir sites.
Our research group has recently found evidence of the latter, that there is active viral replication
occurring in the popliteal lymph node in the asymptomatic phase in spite of apparent peripheral
blood latency [11]. However, we also recognize that due to the inherent limitations of the real-time
PCR assay (1 ˆ 10e3 copies/mL plasma) it is possible that replication is occurring in the peripheral
blood below the level of detection of our assay. Previous investigations into the stability of the proviral
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LTR and gag regions by our group demonstrated minimal to no sequence variation between zero and
62 wpi [4]. These results are surprising, given that active viral replication was readily detectable in the
peripheral blood (detectable plasma and cell-associated viral gag RNA) in the early infection stage.
Perhaps proviral sequence variation was not detected in the early phase of infection because mutated
variants were rare relative to a large proviral pool of the inoculating viral variant.
We repeatedly identified three SNPs within the proviral LTR in this cohort of experimentally
infected cats. It is less surprising that the SNP within the U5 region (T329G) was commonly amplified,
as it was discovered as a rare variant present in the inoculating virus stock, though it was not
seen in vivo until the late asymptomatic phase of infection. Replication incompetent HIV proviruses
have been shown to be the result of viral sequence changes such hypermutation or large sequence
deletions [15]. Our research group has demonstrated that a SNP in a critical position (like a TFBS)
can dramatically alter the transcriptional functionality of the promoter [4]. In the current study
we identified an interesting naturally occurring insertional direct repeat within the U3 region that
significantly augmented promoter functionality. This may be the result of duplication of specific TFBS,
or alternatively, the presence of tandem TATA boxes within this mutated proviral clone. In other
lentiviral systems, the presence or absence of certain TFBS within the proviral U3 region has been
demonstrated to affect the ability of the viral promoter to respond to cytokine-mediated activation [13].
It is interesting that most of the LTR SNPs amplified from these cats occurred in the U3 region, which
contains eight known TFBS. SNPs were detected in all TFBS. It was not determined if the amplified
proviral sequences were transcriptionally (replication) competent. It would be interesting to know the
effect on promoter functionality and replication competency of all of these variants.
It is also interesting to note that all three commonly amplified LTR SNPs were eventually detected
in all four of our FIV-infected cats, with the exception of the G93A mutation, which was not amplified
from cat 186. The predisposing factor(s) that leads to the accumulation of these SNPs remains enigmatic,
but it is unlikely to be dependent upon the individual animal. We have previously demonstrated
that the mitogen concanavalin-A is able to induce the occurrence of the G93A and C102A proviral LTR
mutations in ex vivo cultured CD4+ cells [6]. In the current study we also demonstrated that these
proviral sequence mutations were present in multiple types of peripheral leukocytes (CD4+ and CD21+
cells) as well as in leukocytes derived from lymphoid tissues, consistent with previous literature which
supports these leukocyte subsets as important viral reservoirs [11,16]. The significance of promoter
SNPs identified solely within PLN-derived leukocytes is yet to be determined. One could postulate
that they may alter or abrogate promoter functionality, or alternatively that the mutation may confer
specific lymphoid tissue tropism. It was not surprising that proviral DNA was not amplified from
peripheral blood at the 274–290 wpi time point from two FIV-infected cats because the absolute CD4+
count of cat 165 was extremely low (98 CD4+ cells/µL) and thus cell-associated provirus is very rare.
The other cat (187) that we failed to amplify provirus from peripheral CD4+ cells has a very low total
proviral load and is considered to be a long term non-progressor [11].
In addition to the many mutations amplified in the FIV LTR, we also detected multiple proviral
mutations in the proximal ~1000 nucleotides of FIV gag from PLN-derived cells. Whether these gag
mutations affected viral replication function was not determined. Our group previously documented
proviral sequence stability of the same gag leader region during the early asymptomatic phase (up
to 57 wpi) from PBMC-derived gDNA in this cohort of cats, similar to what was identified for the
LTR [4]. The gag leader region contains coding segments required for efficient viral packaging, the
primer binding site and splice donor sequences, but also includes a locus within the 3’ aspect of the
FIV gag leader region not constrained by encapsidation sequence requirements and with no known
gene coding function [14]. We did not detect any mutations in the primer binding or splice donor sites.
Regions within the open reading frames of MA and CA can vary considerably (up to 84%) between
different geographic isolates of FIV [17], which also suggests that strict genetic stability in the gag
sequence is not essential for the virus. Tolerable laxity in the proviral gag sequence has been identified
in other immunodeficiency inducing retroviruses. Queen et al. demonstrated that many gag mutations
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arising in chronically SIV-infected macaques remain replication competent [18]. As well, mutations
predicted to reduce efficient packaging of HIV do not in fact do so [19].
5. Conclusions
In conclusion, this cohort of experimentally-FIV infected cats in the late asymptomatic phase
demonstrates proviral genomic instability in the LTR and 5’ aspect of gag in spite of undetectable viral
replication in the peripheral blood. Genomic mutations in the proviral LTR may affect the function of
the FIV promoter and viral replication. However, some mutations may be silent. Collectively, these
findings suggest that peripheral blood may not be an accurate indicator of viral activity during the
asymptomatic phase. Further investigations in various tissue reservoirs and viral replication within
tissues during the asymptomatic phase are warranted.
Acknowledgments: The authors are grateful for the excellent animal care provided by Monica Durden and the
staff of the University of California Davis Feline Research Laboratory. The authors would like to acknowledge
Ed Hoover and Niels Pedersen for providing the biological isolate of FIV-C-Pgmr. Funding for this study
was provided, in part, by the Center for Companion Animal Health, Bernice Barbour Foundation and the
Graduate Student Support System Fellowship, School of Veterinary Medicine; and the UC Davis Graduate Studies
Dissertation Year Fellowship, University of California, Davis, CA, USA. The authors are also grateful for the
editing assistance of Kirsten Murphy.
Author Contributions: Christina D. Eckstrand and Brian conceived and designed the experiments;
Chadwick Hillman and Christina D. Eckstrand performed the experiments; Christina D. Eckstrand and
Brian G. Murphy analyzed the data and Christina D. Eckstrand wrote the manuscript.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Pedersen, N.C.; Ho, E.W.; Brown, M.L.; Yamamoto, J.K. Isolation of a T-lymphotropic virus from domestic
cats with an immunodeficiency-like syndrome. Science 1987, 235, 790–793. [CrossRef] [PubMed]
2. Yamamoto, J.K.; Sparger, E.; Ho, E.W.; Andersen, P.R.; O’Connor, T.P.; Mandell, C.P.; Lowenstine, L.; Munn, R.;
Pedersen, N.C. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats.
Am. J. Vet. Res. 1988, 49, 1246–1258. [PubMed]
3. McDonnel, S.J.; Sparger, E.E.; Murphy, B.G. Feline immunodeficiency virus latency. Retrovirology 2013, 10.
[CrossRef] [PubMed]
4. Murphy, B.; Vapniarsky, N.; Hillman, C.; Castillo, D. FIV establishes a latent infection in feline peripheral
blood CD4+ T lymphocytes in vivo during the asymptomatic phase of infection. Retrovirology 2012, 9.
[CrossRef] [PubMed]
5. McDonnel, S.J.; Sparger, E.E.; Luciw, P.A.; Murphy, B.G. Transcriptional regulation of latent feline
immunodeficiency virus in peripheral CD4+ T-lymphocytes. Viruses 2012, 4, 878–888. [CrossRef] [PubMed]
6. Murphy, B.; Hillman, C.; McDonnel, S. Peripheral immunophenotype and viral promoter variants during
the asymptomatic phase of feline immunodeficiency virus infection. Virus Res. 2014, 179, 34–43. [CrossRef]
[PubMed]
7. Menéndez-Arias, L. Mutation rates and intrinsic fidelity of retroviral reverse transcriptases. Viruses 2009, 1,
1137–1165. [CrossRef] [PubMed]
8. Svarovskaia, E.S.; Cheslock, S.R.; Zhang, W.-H.; Hu, W.-S.; Pathak, V.K. Retroviral mutation rates and reverse
transcriptase fidelity. Front. Biosci. 2003, 8, d117–d134. [PubMed]
9. Meyerhans, A.; Jung, A.; Maier, R.; Vartanian, J.-P.; Bocharov, G.; Wain-Hobson, S. The non-clonal and
transitory nature of HIV in vivo. Swiss Med. Wkly. 2003, 133, 451–454. [PubMed]
10. Diehl, L.J.; Mathiason-Dubard, C.K.; O’Niel, L.L.; Obert, L.A.; Hoover, E.A. Induction of accelerated feline
immunodeficiency virus disease by acute-phase viral passage. J. Virol. 1995, 69, 6149–6157. [PubMed]
11. Eckstrand, C.; Hillman, C.; Smith, A.; Sparger, E.; Murphy, B. Viral reservoirs in lymph nodes of FIV-infected
progressor and long-term non-progressor cats during the asymptomatic phase. PLoS ONE 2016, 11.
[CrossRef] [PubMed]
Vet. Sci. 2016, 3, 10 12 of 12
12. Adams, M.; Sharmeen, L.; Kimpton, J.; Romeo, J.M.; Garcia, J.V.; Peterlin, B.M.; Groudine, M.; Emerman, M.
Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected
by the presence of promoter-proximal transcripts. Proc. Natl. Acad. Sci. USA 1994, 91, 3862–3866. [CrossRef]
[PubMed]
13. Murphy, B.; Hillman, C.; Castillo, D.; Vapniarsky, N.; Rowe, J. The presence or absence of the
gamma-activated site determines IFN gamma-mediated transcriptional activation in CAEV promoters
cloned from the mammary gland and joint synovium of a single CAEV-infected goat. Virus Res. 2012, 163,
537–545. [CrossRef] [PubMed]
14. Browning, M.T.; Mustafa, F.; Schmidt, R.D.; Lew, K.A.; Rizvi, T.A. Sequences within the gag gene of feline
immunodeficiency virus (FIV) are important for efficient RNA encapsidation. Virus Res. 2003, 93, 199–209.
[CrossRef]
15. Ho, Y.-C.; Shan, L.; Hosmane, N.N.; Wang, J.; Laskey, S.B.; Rosenbloom, D.I.S.; Lai, J.; Blankson, J.N.;
Siliciano, J.D.; Siliciano, R.F. Replication-competent noninduced proviruses in the latent reservoir increase
barrier to HIV-1 cure. Cell 2013, 155, 540–551. [CrossRef] [PubMed]
16. Dean, G.; Reubel, G. Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte
subsets of blood and lymph node. J. Virol. 1996, 70, 5165–5169. [PubMed]
17. Report, B.; Park, R.; Health, P.; Service, I.; Animal, F.; Diagnostic, D. Nucleotide sequences of Australian
isolates of the feline immunodeficiency virus: Comparison with other feline lentiviruses. Arch. Virol. 1993,
132, 369–379.
18. Queen, S.E.; Mears, B.M.; Kelly, K.M.; Dorsey, J.L.; Liao, Z.; Dinoso, J.B.; Gama, L.; Adams, R.J.; Zink, M.C.;
Clements, J.E.; et al. Replication-competent simian immunodeficiency virus (SIV) gag escape mutations
archived in latent reservoirs during antiretroviral treatment of SIV-infected macaques. J. Virol. 2011, 85,
9167–9175. [CrossRef] [PubMed]
19. Nikolaitchik, O.; Rhodes, T.D.; Ott, D.; Hu, W. Effects of mutations in the human immunodeficiency virus
type 1 gag gene on RNA packaging and recombination. Society 2006, 80, 4691–4697. [CrossRef] [PubMed]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
